Literature DB >> 29674241

Protective effect of betulinic acid against intracerebroventricular streptozotocin induced cognitive impairment and neuronal damage in rats: Possible neurotransmitters and neuroinflammatory mechanism.

Madhu Kaundal1, Rahul Deshmukh1, Mohd Akhtar2.   

Abstract

BACKGROUND: The purpose of the study was to explore the therapeutic potential of Betulinic acid (BA) in streptozotocin (STZ) induced memory damage in experimental rats.
METHODS: STZ (3mg/kg bilaterally) as intracerebroventrical (icv) route was administered on day 1 and 3 in rats. Donepezil (5mg/kg/day po), used as standard, and BA (5, 10 and 15mg/kg/day po) were administered after 1h of 1st STZ infusion up to 21days. Object recognition task (ORT) for non-spatial, Morris water maze (MWM) for spatial and locomotor activity were performed to evaluate behavioral changes in rats. On 22nd day, animals were decapitated and hippocampus was separated to perform biochemical (AChE, LPO, GSH, nitrite), neuroinflammatory (TNF-α, IL-1β, and IL-6), neurotransmitters (NTs) (dopamine, norepinephrine and serotonin) analysis.
RESULTS: STZ infusion significantly impaired memory as observed in MWM and ORT, increased oxidative stress, pro-inflammatory cytokine's level and altered NTs level. Moreover, BA demonstrated a neuroprotective effect in a dose-dependent manner. BA dose dependently (5, 10 and 15mg/kg) significantly restore STZ induced memory changes and pathological abnormalities in rat brain.
CONCLUSIONS: The findings of the current study suggests that BA protect rat brain from STZ induced neuronal damage via acting through multiple mechanisms and would be used to curb cognitive decline associated with neurodegenerative disorders especially AD.
Copyright © 2017 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Betulinic acid; Neuroinflammation; Neurotransmitters

Mesh:

Substances:

Year:  2017        PMID: 29674241     DOI: 10.1016/j.pharep.2017.11.020

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  9 in total

1.  Roflumilast Reduces Pathological Symptoms of Sporadic Alzheimer's Disease in Rats Produced by Intracerebroventricular Streptozotocin by Inhibiting NF-κB/BACE-1 Mediated Aβ Production in the Hippocampus and Activating the cAMP/BDNF Signalling Pathway.

Authors:  Noorul Hasan; Saima Zameer; Abul Kalam Najmi; Suhel Parvez; Mohd Akhtar
Journal:  Neurotox Res       Date:  2022-02-22       Impact factor: 3.911

2.  Diterpenoid Caesalmin C Delays Aβ-Induced Paralysis Symptoms via the DAF-16 Pathway in Caenorhabditis elegans.

Authors:  Zong-Ping Zhang; Xue Bai; Wen-Bo Cui; Xiao-Han Chen; Xu Liu; De-Juan Zhi; Zhan-Xin Zhang; Dong-Qing Fei; Dong-Sheng Wang
Journal:  Int J Mol Sci       Date:  2022-06-20       Impact factor: 6.208

3.  Roflumilast and tadalafil improve learning and memory deficits in intracerebroventricular Aβ1-42 rat model of Alzheimer's disease through modulations of hippocampal cAMP/cGMP/BDNF signaling pathway.

Authors:  Noorul Hasan; Saima Zameer; Abul Kalam Najmi; Suhel Parvez; Mohammad Shahar Yar; Mohd Akhtar
Journal:  Pharmacol Rep       Date:  2021-04-15       Impact factor: 3.024

Review 4.  Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease.

Authors:  Jelena Osmanovic Barilar; Ana Knezovic; Ana Babic Perhoc; Jan Homolak; Peter Riederer; Melita Salkovic-Petrisic
Journal:  J Neural Transm (Vienna)       Date:  2020-02-06       Impact factor: 3.575

5.  Pantao Pill Improves the Learning and Memory Abilities of APP/PS1 Mice by Multiple Mechanisms.

Authors:  Qiqi Xin; Weili Shi; Yan Wang; Rong Yuan; Yu Miao; Keji Chen; Weihong Cong
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810

Review 6.  Secondary Metabolites with Biomedical Applications from Plants of the Sarraceniaceae Family.

Authors:  Ileana Miclea
Journal:  Int J Mol Sci       Date:  2022-08-30       Impact factor: 6.208

Review 7.  Recent Advances Regarding the Molecular Mechanisms of Triterpenic Acids: A Review (Part II).

Authors:  Marius Mioc; Alexandra Prodea; Roxana Racoviceanu; Alexandra Mioc; Roxana Ghiulai; Andreea Milan; Mirela Voicu; Gabriel Mardale; Codruța Șoica
Journal:  Int J Mol Sci       Date:  2022-08-10       Impact factor: 6.208

8.  Neuromodulatory effects of green coffee bean extract against brain damage in male albino rats with experimentally induced diabetes.

Authors:  Ashraf Al-Brakati; Alaa Jameel A Albarakati; Hamid M A Daabo; Roua S Baty; Fatma Elzahraa H Salem; Ola A Habotta; Ehab K Elmahallawy; Doaa M Abdel-Mohsen; Heba Taha; Ahmed M A Akabawy; Rami B Kassab; Ahmed E Abdel Moneim; Hatim K Amin
Journal:  Metab Brain Dis       Date:  2020-06-16       Impact factor: 3.584

9.  Betulinic Acid Hydroxamate is Neuroprotective and Induces Protein Phosphatase 2A-Dependent HIF-1α Stabilization and Post-transcriptional Dephosphorylation of Prolyl Hydrolase 2.

Authors:  María E Prados; Alejandro Correa-Sáez; Juan D Unciti-Broceta; Martín Garrido-Rodríguez; Carla Jimenez-Jimenez; Massimiliano Mazzone; Alberto Minassi; Giovanni Appendino; Marco A Calzado; Eduardo Muñoz
Journal:  Neurotherapeutics       Date:  2021-08-02       Impact factor: 7.620

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.